Corporate News

  • ACCURAY NEWS OCTOBER 2020

    New Book Offers CyberKnife® NeuroRadiosurgery Insights

    Evidence-backed treatment techniques and best practices from top researchers and practitioners CyberKnife® NeuroRadiosurgery Insights

    CyberKnife® NeuroRadiosurgery is a comprehensive practical guide based on real-world clinical experiences — backed by tables, summaries and analysis — that sheds light on potential treatment approaches and associated risks of neuroradiosurgery.

    More information

  • ELEKTA NEWS OCTOBER 2020

    Leksell Gamma Knife Lightning A simple solution for accelerated radiosurgery

    As the demand for SRS and SBRT grows, Elekta is committed to providing precision radiation, medicine to all patients around the world. By offering advanced, personalized and accessible treatments, Elekta continues to push the boundaries of stereotactic excellence and provide solutions that meet the clinical needs of today and tomorrow.

    More information

  • RT-SAFE NEWS OCTOBER 2020

    Prime phantom and remote dosimetry services: A combination for advanced QA in SRS

    Gamma Knife End-to-End verification

    Gamma Knife radiosurgery is considered as the best treatment choice for all types of brain lesions (malignant or benign) and functional disorders of the brain. The introduction of the latest Gamma Knife treatment system, the Leksell Gamma Knife® IconTM, has extended the treatment options that Gamma Knife offers to single or hypo-fractionated Stereotactic Radiosurgery (SRS) treatments, using a stereotactic frame or a frameless thermoplastic mask, and can treat small or larger tumor volumes. A cone-beam computed tomography (CBCT) and a high-definition motion management system have been integrated allowing for frameless patient positioning and monitoring. Treatment Planning System is performed by Leksell GammaPlan® which includes the commonly used Tissue-Maximum-Ratio (TMR) and the recently introduced Convolution algorithms. The Convolution algorithm is based on a combination of the collapsed cone convolution and the pencil beam convolution offering a dose engine specifically designed for the calculation of the deposited dose in heterogeneous tissues.           

    More information

  • VARIAN NEWS OCTOBER 2020

    Studies Validate HyperArc® High-Definition Radiotherapy as a Valid Approach to SRS

    This material was excerpted from a longer article covering a broader range of studies.  You can access the full version online here: www.varian.com/hyperarc-studies.

    When a new treatment technology comes on the scene, clinicians naturally want to be assured that it meets or exceeds the performance of established and familiar ones. Since HyperArc® high-definition radiotherapy was introduced at ASTRO in 2016, at least 80 centers have delivered HyperArc treatments for thousands of patients. From those centers, at least 14 independently conducted studies have demonstrated that HyperArc can be used with confidence for stereotactic radiosurgery (SRS). HyperArc plans for delivery on Edge® or TrueBeam® systems are shown to be comparable to plans for other SRS approaches, often with significant benefits in delivery time.  

    More information

  • RTSAFE NEWS JUNE 2020

    RTsafe provides powerful tools for SRS users

    ‘’At RTsafe, our scientific team creates personalized solutions that not only meet your current needs but also empower you to adopt new, innovative techniques with confidence.’’

    More information

  • RTSAFE NEWS MAY 2020

    RTsafe offers film dosimetry services free of charge during COVID-19 crisis period

    As a small token of gratitude to frontline health workers fighting the COVID-19 pandemic, RTsafe offers the Remote Film Dosimetry Service free of charge providing the fellow radiotherapy professionals with tangible support.

    More information

  • ELEKTA NEWS MAY 2020

    Cancer doesn't care about COVID-19: Maintaining cancer treatment regimens in times of crisis is our priority

    Long before the start of the COVID-19 pandemic, Elekta was committed to innovating remote-access software solutions that help to ensure the safe and effective delivery of radiotherapy. These solutions include software systems as well as customer care and support services.

    Today, Elekta is leveraging these capabilities in new ways to help customers continue to provide optimum treatments to their patients during the COVID-19 pandemic, which has disrupted almost every aspect of healthcare, including radiation therapy.

    More information

  • VARIAN NEWS MAY 2020

    Assistance for Customers During the COVID-19 Pandemic

    At Varian, we know you are faced with numerous challenges as you continue to treat patients during this pandemic. You are dealing with demands such as new remote work environments, the need to reduce unnecessary onsite patient visits, staffing reductions, and the challenge of tracking COVID-19-positive patients.

    More information

  • ACCURAY NEWS MAY 2020

    Accuray supports its customers during COVID19

    During these difficult and trying times of the COVID19 pandemic, Accuray has come together with its customers to provide innovative ways to assist them to be able to continue to care for their cancer patients.

    As one initiative, Accuray’s Medical Affairs team is ready to provide customers with information regarding peer reviewed, published clinical literature. While its customers may be experiencing staff disruptions and shortages in qualified clinical staff, Accuray provides remote product training and clinical application’s support, a benefit of Accuray’s service agreements, to quickly train and educate new users.

    More information

  • Elekta news October 2019

    As the demand and ambition for SRS and SBRT grow, Elekta is dedicated to make advanced treatments more personalized, operationally efficient and accessible to all patients around the world.
    Elekta continues to push the boundaries of stereotactic treatment and provide solutions that meet the clinical needs of today and tomorrow.

    More information

  • Varian news October 2019

    Tracking Tumors with Calypso at The University Of Kansas Cancer Center: “Like Working In The Light”

    When the University of Kansas Cancer Center (KUCC) acquired a linear accelerator in 2013, Habeeb Saleh, Ph.D., DABR, the center’s chief of medical physics, requested that the purchase include Calypso™ technology for soft tissue stereotactic body radiotherapy (SBRT). His colleague, Zachary Collins, M.D., also advocated for Calypso based on its growing word-of-mouth reputation and reported advantages for tumor tracking.

    More information

  • RTsafe news October 2019

    End-to-end spatial accuracy of single-isocenter linac-based SRS for multiple brain metastases: An experimental 3D dose verification study using RTsafe´s PseudoPatientTM technology.

    More information

  • RTSAFE NEWS December 2018

    Hygeia Hospital Adopts RTsafe Technology to Enhance Patient-specific Safety in Brain Cancer Radiotherapy




    More information